Senkyunolide A Protects Neural Cells against Corticosterone-Induced Apoptosis by Modulating Protein Phosphatase 2A and α-Synuclein Signaling [Retraction]

Abstract

Gong S, Zhang J, Guo Z, Fu W. Drug Des Devel Ther. 2018;12:1865–1879. The Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of flow cytometry images in Figures 3A, 4E, 7C and 9E. The authors responded to our queries but were unable to provide a satisfactory explanation for the alleged duplication nor were they able to provide the original flow cytometry data for their study. The Editor determined the results of the study were invalid and requested for the article to be retracted. The authors agreed with this decision. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper

Keywords

• α-synuclein
• corticosterone
• depression
• neuroprotection
• protein phosphatase 2a
• senkyunolide a